Emily Y. Liu

发表

Phenotypic characteristics in metabolically obese but normal weight non-diabetic patients with schizophrenia

D. Goff, Jijun Wang, O. Freudenreich, 2010, Schizophrenia Research.

No Effect of Adjunctive, Repeated-Dose Intranasal Insulin Treatment on Psychopathology and Cognition in Patients With Schizophrenia

D. Goff, O. Freudenreich, D. Henderson, 2013, Journal of clinical psychopharmacology.

No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia

D. Goff, O. Freudenreich, D. Henderson, 2013, Schizophrenia Research.

Does low bone mineral density start in post-teenage years in women with type 1 diabetes?

J. Dmochowski, J. Wactawski‐Wende, T. Quattrin, 2003, Diabetes care.

No Effect of Single-Dose Intranasal Insulin Treatment on Verbal Memory and Sustained Attention in Patients With Schizophrenia

D. Goff, O. Freudenreich, D. Henderson, 2011, Journal of clinical psychopharmacology.

Higher fasting serum insulin levels are associated with a better psychopathology profile in acutely ill non-diabetic inpatients with schizophrenia

D. Goff, D. Henderson, Xiaoduo Fan, 2006, Schizophrenia Research.

Obese Children Who Are Referred to the Pediatric Endocrinologist: Characteristics and Outcome

T. Quattrin, B. Shine, Emily Y. Liu, 2005, Pediatrics.

Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia

D. Goff, Jijun Wang, O. Freudenreich, 2010, Schizophrenia Research.

Diminished insulin resistance with weight loss in severely overweight youth.

L. Epstein, A. Rogol, T. Quattrin, 2004, Metabolic syndrome and related disorders.

Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia

D. Goff, O. Freudenreich, D. Henderson, 2007, Psychiatry Research.

Triglyceride/high-density lipoprotein cholesterol ratio: a surrogate to predict insulin resistance and low-density lipoprotein cholesterol particle size in nondiabetic patients with schizophrenia.

D. Henderson, A. J. Potts, Xiaoduo Fan, 2011, The Journal of clinical psychiatry.